Compare Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs Roivant Sciences Ltd. Common Shares — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.26 (market cap $39.95B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is the larger of the two by market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.2% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| HLN | ROIV | |
|---|---|---|
Market Cap | $39.95B | $25.09B |
Volume | 18,243,581 | 5,738,571 |
Sector | Health | Health |
52-Week High | $11.27 | $41.81 |
52-Week Low | $8.70 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $49.77B | $21.36B |
Dividend Yield | 2.2% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
